Genomic Sequencing in Acutely Ill Neonates

Completed · Not applicable

Conditions studied: Diseases/Diagnoses, Genetic Disease

In brief

The purpose of this study is to compare the effectiveness of rapid next generation sequencing (NGS, such as whole genome sequencing1) with current practice to provide diagnostic or prognostic information or treatment guidance in acutely ill neonates and infants, particularly with respect to clinical care, cost and outcomes.

Key facts

Study ID

NCT02225522

Run by

Children's Mercy Hospital Kansas City

People needed

65

Starts

2014-10-01

Expected to finish

2016-09-01

Last updated by the study team

2017-06-23

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Previously confirmed genetic diagnosis that explains the clinical condition
• Has features pathognomonic for a large chromosomal aberration (Trisomy 13, 18, 21 or other)

Where it is running

• Children's Mercy Hospital — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.